Research co-led by UCSF School of Pharmacy faculty member Brian Shoichet, PhD, has developed a new opioid drug candidate that blocks pain as effectively as morphine in mice, without triggering dangerous side effects, and also apparently without the addictive properties of current prescription painkillers.
UCSF student pharmacists Stephanie Golahi and Michelle Fang, both class of 2019, took first place in Division I of the 2016 Student National Pharmaceutical Association (SNPhA)/Kroger Clinical Skills Competition held in Atlanta in late July.
David Adler, PharmD ’70, Distinguished Pharmacy Alumnus 2016.
It was fortuitous that David Adler, PharmD ’70, began his studies at the UCSF School of Pharmacy in the fall of 1966, precisely when UCSF Medical Center’s Ninth Floor Project went into action. That project’s unprecedented placement of pharmacists on a UCSF hospital ward—providing their drug expertise directly to physicians, nurses, and patients—pioneered a radically new clinical role.
Study co-lead author Sook Wah Yee, PhD, of Giacomini Lab
Metformin is the most widely used initial medication for controlling blood sugar (glucose) in type 2 diabetes, a disease affecting 350 million people worldwide. The drug helps reduce their risk of complications leading to heart, eye, and kidney disease.
But there are major differences in metformin response and more than a third of patients fail to achieve acceptable blood glucose control from the drug.
Over the past five years, School of Pharmacy faculty member Eleanor Vogt, PhD, RPh, has co-developed and implemented a program for hundreds of employees of the city and county of San Francisco that imparts tools to reduce stress and increase resiliency.